Ascentage Pharma Group International (AAPG) Current Deferred Revenue (2023 - 2024)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Ascentage Pharma Group International (AAPG) has 2 years of Current Deferred Revenue data on record, last reported at $5.2 million in Q4 2024.

• For Q4 2024, Current Deferred Revenue fell 2.18% year-over-year to $5.2 million; the TTM value through Dec 2024 reached $5.2 million, down 2.18%, while the annual FY2024 figure was $5.2 million, 4.02% down from the prior year.
• Current Deferred Revenue reached $5.2 million in Q4 2024 per AAPG's latest filing, down from $5.3 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $5.3 million in Q4 2023 and bottomed at $5.2 million in Q4 2024.

Peer Comparison